Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05736731
Title A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression (EVEREST-1)
Acronym EVEREST-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors A2 Biotherapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner Health RECRUITING Gilbert Arizona 85234 United States Details
City of Hope WITHDRAWN Duarte California 90101 United States Details
University of California San Diego RECRUITING La Jolla California 92093 United States Details
UCLA Medical Center RECRUITING Los Angeles California 90404 United States Details
Stanford University RECRUITING Stanford California 94305 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33136 United States Details
Mayo Clinic Rochester RECRUITING Rochester Minnesota 55905 United States Details
Washington University RECRUITING Saint Louis Missouri 63110 United States Details
NYU Langone Medical Center RECRUITING New York New York 10016 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field